Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

Blood (2017) 130 (Supplement 1): 57.

https://doi.org/10.1182/blood.V130.Suppl_1.57.57

Published: 2017

Journal Articles

The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial

Blood (2017) 130 (Supplement 1): 259.

https://doi.org/10.1182/blood.V130.Suppl_1.259.259

Published: 2017

Journal Articles

Clinical Importance of DNA Methylation Signatures in Chronic Lymphocytic Leukaemia Patients Treated with Chemo-Immunotherapy

Blood (2017) 130 (Supplement 1): 56.

https://doi.org/10.1182/blood.V130.Suppl_1.56.56

Published: 2017

Journal Articles

Genomic Complexity in Chronic Lymphocytic Leukemia Defined By Array-Based Analysis: Definitions, Associations with Other Biomarkers and Clinical Impact

Blood (2017) 130 (Supplement 1): 4280.

https://doi.org/10.1182/blood.V130.Suppl_1.4280.4280

Published: 2017

Journal Articles

Different Time-Dependent Risk for Disease Evolution in Chronic Lymphocytic Leukemia with Distinct IGHV Gene Somatic Hypermutation Status

Theodoros Moysiadis, PhD BSc, MSc, Panagiotis Baliakas, MD PhD, Davide Rossi, MD PhD, Mark Catherwood, Jonathan C Strefford, PhD, Julio Delgado, MD, Achilles Anagnostopoulos, Chrysoula Belessi, Niki Stavroyianni, Sarka Pospisilova, MD PhD, David Oscier, MD PhD, Gianluca Gaidano, MD PhD, Elias Campo, MD PhD, Richard Rosenquist, MD PhD, Paolo Ghia, Kostas Stamatopoulos

Blood (2017) 130 (Supplement 1): 3001.

https://doi.org/10.1182/blood.V130.Suppl_1.3001.3001

Published: 2017

Journal Articles

Genome-Wide Promoter Methylation Profiling Of Splenic Marginal Zone Lymphoma (SMZL) Identifies Two Subgroups Of Patients With Distinct Genetic and Biologic Features and Different Outcomes

Blood (2013) 122 (21): 77.

https://doi.org/10.1182/blood.V122.21.77.77

Published: 2013

Journal Articles

Mutations In XPO1, POT1, BIRC3 and FBXW7 collectively Predict Poor Outcome At Diagnosis In CLL and MBL Independent From The SF3B1 and NOTCH1 Status

Nils Winkelmann, MD, Mathew J Rose-Zerilli, PhD, Jade Forster, Mathew Parry, PhD, Anton Parker, BSc, Anne Gardiner, Zadie Davies, BSC, Andrew J Steele, PhD, Helen Parker, PhD, Andrew Collins, PhD, Nick C.P. Cross, PhD, David Oscier, MD, Jonathan C Strefford

Blood (2013) 122 (21): 4138.

https://doi.org/10.1182/blood.V122.21.4138.4138

Published: 2013

Journal Articles

Prognostic Assessment In Patients With Chronic Lymphocytic Leukemia (CLL) In Clinical Practice: A European Research Initiative On CLL (ERIC) Survey

Carol Moreno, MD, Stephan Stilgenbauer, MD, Marco Montillo, MD, Robak Tadeusz, MD, Eva Kimby, MD, Richard Rosenquist, MD, PhD, David Oscier, MD

Blood (2013) 122 (21): 4156.

https://doi.org/10.1182/blood.V122.21.4156.4156

Published: 2013

Journal Articles

The Correlation Between Deletion Architecture, ATM Mutational Status and BIRC3 Disruption in 11q-Deleted CLL

Matthew JJ Rose-Zerilli, PhD, Jade Forster, Helen Parker, PhD, Anton Parker, Ana E Rodríguez, Tracy Chaplin, Anne Gardiner, Andrew Collins, PhD, Bryan D Young, PhD, Tatjana Stankovic, MD., PhD, David Oscier, MD, Jonathan C. Strefford, BSc, PhD

Blood (2012) 120 (21): 658.

https://doi.org/10.1182/blood.V120.21.658.658

Published: 2012

Journal Articles

Biallelic ATM Inactivation Significantly Reduces Survival in Chronic Lymphocytic Leukemia Patients Treated with Alkylating Agent/Purine Analogue Therapy: Results From the UKCLL4 Trial

Anna Skowronska, Gulshanara Ahmed, Ceri E Oldreive, PhD, David Oscier, MD, Anton Parker, Martin J.S. Dyer, MA, DPhil, Estella Matutes, MD, PhD, A. Malcolm R Taylor, PhD, Paul AH Moss, MD PhD, Tatjana Stankovic, MD PhD

Blood (2011) 118 (21): 467.

https://doi.org/10.1182/blood.V118.21.467.467

Published: 2011

Journal Articles

Distinctive Patterns of Intraclonal Diversification In IGHV1-2*04 Immunoglobulin Receptors of Patients with Splenic Marginal Zone Lymphoma: A of Ongoing Interactions with Antigen?

Blood (2011) 118 (21): 2638.

https://doi.org/10.1182/blood.V118.21.2638.2638

Published: 2011

Journal Articles

Telomere Length Is An Independent Predictor of Outcome After Therapy in CLL: Results From the UKCLL4 Trial,

Anton Parker, Jade Forster, Stacey Reichter, David Gonzalez de Castro, PhD, Daniel Catovsky, MD, David Oscier, MD

Blood (2011) 118 (21): 3884.

https://doi.org/10.1182/blood.V118.21.3884.3884

Published: 2011

Journal Articles

The Outcome of CLL Patients with 97% Identity to Germline Is Inferior to Other ‘Mutated’ Cases Defined by a 98% Cut off

Zadie Davis, PhD, Anton Parker, Daniel Catovsky, MD, David Oscier, MD

Blood (2011) 118 (21): 2842.

https://doi.org/10.1182/blood.V118.21.2842.2842

Published: 2011

Journal Articles

An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL).

Peter Hillmen, MB, ChB, PhD, John G. Gribben, MD, DSc, George A Follows, Donald W. Milligan, MD, MBChB, Hazem A. Sayala, MBChB, MRCP, Paul Moreton, David Oscier, MD, Claire E. Dearden, MD, Daniel B. Kennedy, Andrew R. Pettitt, PhD, MRCPath, Amit Nathwani, MD, PhD, Dena Cohen, Walter M Gregory, Andy C. Rawstron, PhD, Colin R.W. Hayward, MBBS, Christopher Pocock

Blood (2009) 114 (22): 3428.

https://doi.org/10.1182/blood.V114.22.3428.3428

Published: 2009

Journal Articles

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

Nicholas C.P. Cross, PhD, FRCPath, Peter Campbell, MD, PhD, Philip A Beer, BM, MRCP, MRCPath, Susanne Schnittger, PhD, Alessandro M. Vannucchi, MD, Katerina Zoi, PhD, Melanie Percy, PhD, FRCPath, Mary Frances McMullin, Linda Scott, BSc, PhD, Richard T. Silver, MD, David Oscier, MD, Claire Harrison, MD, Anthony R. Green, FRCP, FRCPath, FMed, Sci, Andrew Chase, PhD

Blood (2009) 114 (22): 433.

https://doi.org/10.1182/blood.V114.22.433.433

Published: 2009

Journal Articles

Development of V617F JAK2 Associated Myeloproliferative Neoplasms Is a Non-Random Event That Is Strongly Dependent on JAK2 Haplotype

Nicholas C.P. Cross, PhD, Amy V. Jones, BSc, Richard T. Silver, MD, David Oscier, MD, Georgia Metzgeroth, MD, Y. Lynn Wang, MD, PhD, Andrew Collins, PhD, Andreas Reiter, MD, Francis Grand, PhD, Andrew Chase, PhD

Blood (2008) 112 (11): 173.

https://doi.org/10.1182/blood.V112.11.173.173

Published: 2008

Journal Articles

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

Francis Grand, PhD, Claire Hidalgo-Curtis, BSc, Thomas Ernst, MD, Katerina Zoi, PhD, Christine Zoi, MD, Carolann McGuire, PhD, Sebastian Kreil, MD, Georgia Metzgeroth, MD, David Oscier, MD, Andrew Hall, PhD, Christian Brandts, MD, Hubert Serve, Andreas Reiter, MD, Andrew Chase, PhD, Nicholas C.P. Cross, PhD

Blood (2008) 112 (11): 174.

https://doi.org/10.1182/blood.V112.11.174.174

Published: 2008

Journal Articles

No Significant Molecular Response in Polycythemia Vera Patients Treated with Imatinib or Interferon alpha.

Amy V. Jones, BSc, Katherine Higley, BSc, Claire Curtis, BSc, Sebastian Kreil, MD, Katerina Zoi, MSc, Andreas Hochhaus, MD, Andreas Reiter, MD, David Oscier, MD, Alec Merber, BSc, Richard T. Silver, MD, Nicholas C.P. Cross, PhD

Blood (2005) 106 (11): 373.

https://doi.org/10.1182/blood.V106.11.373.373

Published: 2005

NARROW

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial

Clinical Importance of DNA Methylation Signatures in Chronic Lymphocytic Leukaemia Patients Treated with Chemo-Immunotherapy

Genomic Complexity in Chronic Lymphocytic Leukemia Defined By Array-Based Analysis: Definitions, Associations with Other Biomarkers and Clinical Impact

Different Time-Dependent Risk for Disease Evolution in Chronic Lymphocytic Leukemia with Distinct IGHV Gene Somatic Hypermutation Status

Genome-Wide Promoter Methylation Profiling Of Splenic Marginal Zone Lymphoma (SMZL) Identifies Two Subgroups Of Patients With Distinct Genetic and Biologic Features and Different Outcomes

Mutations In XPO1, POT1, BIRC3 and FBXW7 collectively Predict Poor Outcome At Diagnosis In CLL and MBL Independent From The SF3B1 and NOTCH1 Status

Prognostic Assessment In Patients With Chronic Lymphocytic Leukemia (CLL) In Clinical Practice: A European Research Initiative On CLL (ERIC) Survey

The Correlation Between Deletion Architecture, ATM Mutational Status and BIRC3 Disruption in 11q-Deleted CLL

Biallelic ATM Inactivation Significantly Reduces Survival in Chronic Lymphocytic Leukemia Patients Treated with Alkylating Agent/Purine Analogue Therapy: Results From the UKCLL4 Trial

Distinctive Patterns of Intraclonal Diversification In IGHV1-2*04 Immunoglobulin Receptors of Patients with Splenic Marginal Zone Lymphoma: A of Ongoing Interactions with Antigen?

Telomere Length Is An Independent Predictor of Outcome After Therapy in CLL: Results From the UKCLL4 Trial,

The Outcome of CLL Patients with 97% Identity to Germline Is Inferior to Other ‘Mutated’ Cases Defined by a 98% Cut off

An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL).

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

Development of V617F JAK2 Associated Myeloproliferative Neoplasms Is a Non-Random Event That Is Strongly Dependent on JAK2 Haplotype

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

No Significant Molecular Response in Polycythemia Vera Patients Treated with Imatinib or Interferon alpha.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only